[Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli]

[Article in French]

Clinical Trial

[Article in French]

J Prignot et al. Acta Tuberc Pneumol Belg. 1969.

. 1969;60(3):487-95.

No abstract available

Similar articles

[Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Freerksen E. Freerksen E. Dtsch Med Wochenschr. 1970 Jan 16;95(3):139-41. Dtsch Med Wochenschr. 1970. PMID: 5411222 German. No abstract available.
[Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
Weill G, Lévy A, Guignon JP, Lecoq H, Friess JM, Maman P. Weill G, et al. Rev Tuberc Pneumol (Paris). 1969 Dec;33(8):1119-25. Rev Tuberc Pneumol (Paris). 1969. PMID: 4916253 Clinical Trial. French. No abstract available.
[3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
Hennebert A. Hennebert A. Acta Tuberc Pneumol Belg. 1969;60(3):507-12. Acta Tuberc Pneumol Belg. 1969. PMID: 5371675 French. No abstract available.
Rifapentine for the treatment of pulmonary tuberculosis.
Munsiff SS, Kambili C, Ahuja SD. Munsiff SS, et al. Clin Infect Dis. 2006 Dec 1;43(11):1468-75. doi: 10.1086/508278. Epub 2006 Oct 24. Clin Infect Dis. 2006. PMID: 17083024 Review.
Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J. Grosset J. Clin Chest Med. 1980 May;1(2):231-41. Clin Chest Med. 1980. PMID: 6794976 Review. No abstract available.

A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.
[No authors listed] [No authors listed] Pneumonologie. 1975 Dec 12;153(1):43-59. doi: 10.1007/BF02096334. Pneumonologie. 1975. PMID: 1105471 Clinical Trial. No abstract available.